Works matching IS 09255710 AND DT 2023 AND VI 117 AND IP 3
Results: 21
Correction to: Refined ultrasonographic criteria for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 331, doi. 10.1007/s12185-023-03552-8
- By:
- Publication type:
- Article
Inclusion of thymic Langerhans cell histiocytosis in the "5 Ts" of the differential diagnosis of anterior mediastinal mass.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Detection of Candida albicans in the peripheral blood smear of a diffuse large B cell lymphoma patient.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Progress in pathophysiological understanding and treatment of thrombocytopenia.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 341, doi. 10.1007/s12185-022-03516-4
- By:
- Publication type:
- Article
Recent progress in ITP treatment.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 316, doi. 10.1007/s12185-022-03527-1
- By:
- Publication type:
- Article
Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 349, doi. 10.1007/s12185-022-03512-8
- By:
- Publication type:
- Article
Real-world bleeding outcomes and product utilization in people with severe-type hemophilia A before and after switching to extended half-life rFVIIIFc prophylaxis therapy.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 378, doi. 10.1007/s12185-022-03503-9
- By:
- Publication type:
- Article
Endothelial function testing before conditioning therapy is useful for predicting transplant-related complications after allogeneic hematopoietic cell transplantation.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 438, doi. 10.1007/s12185-022-03498-3
- By:
- Publication type:
- Article
Current childhood chronic myeloid leukemia management under tyrosine kinase inhibitor treatment.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 446, doi. 10.1007/s12185-022-03497-4
- By:
- Publication type:
- Article
The efficacy and safety of caplacizumab in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura: an open-label phase 2/3 study.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 366, doi. 10.1007/s12185-022-03495-6
- By:
- Publication type:
- Article
A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 409, doi. 10.1007/s12185-022-03494-7
- By:
- Publication type:
- Article
Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 pandemic: a single center experience.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 428, doi. 10.1007/s12185-022-03493-8
- By:
- Publication type:
- Article
Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 421, doi. 10.1007/s12185-022-03489-4
- By:
- Publication type:
- Article
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 388, doi. 10.1007/s12185-022-03488-5
- By:
- Publication type:
- Article
Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 356, doi. 10.1007/s12185-022-03487-6
- By:
- Publication type:
- Article
Age and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 398, doi. 10.1007/s12185-022-03486-7
- By:
- Publication type:
- Article
Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 456, doi. 10.1007/s12185-022-03463-0
- By:
- Publication type:
- Article
Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 463, doi. 10.1007/s12185-022-03459-w
- By:
- Publication type:
- Article